Broxil® 125 mg / 5 ml, 250 mg and 500 mg

  • Product

    Broxil 125 mg / 5 ml, powder for oral suspension
    Broxil 250 mg, hard capsules
    Broxil 500 mg, hard capsules

  • Authorisation

    NL-RVG 02672; NL-RVG 04959; NL-RVG 09101

  • Active ingredient

    Pheneticillin (as pheneticillin potassium)

  • Indication

    Non-severe to moderately severe infections, particularly Streptococcus

  • Storage condition

    Between 15 – 25 °C

Broxil is a narrow-spectrum antibiotic and contains the gastric acid-stable penicillin derivative pheneticillin potassium.

Broxil is used to treat infections caused by Streptococci and certain species of Staphylococci.

  • Upper respiratory tract infections like pharyngitis
  • Lower respiratory tract infections like pneumonia
  • Infections of skin (e.g. erysipelas) and soft tissue like impetigo or abscesses

Broxil is available in 250 mg and 500 mg capsules as well as 125 mg/5 ml powder for oral suspension.

Legal status

Broxil is a licensed medicine in the Netherlands.

When this medicine is supplied outside the Netherlands, it is considered to be an unlicensed medicine in the country of the recipient.

Availability for Pharmacies

In the Netherlands, Broxil is distributed to pharmacies by the pharmaceutical wholesalers.

Pharmacies outside the Netherlands that would like to know more about the availability of this product are welcome to contact us via our contact form.